Scientists crack structure of enzyme complex linked to cancer

February 7, 2018, University of California - Riverside
Image shows the DNMT3A-DNA complex. A research team led by Jikui Song cracked the crystal structure for DNMT3A-DNA complex. The structure reveals that DNMT3A molecules attack two substrate sites adjacent to each other on the same DNA molecule. DNMT3L (green) is a regulatory protein of DNMT3A. Bp (base pairs) is a unit of length, with one bp corresponding to approximately 3.4 Å of length along the DNA (brown) strand. Credit: Song lab, UC Riverside.

A research team led by a biochemist at the University of California, Riverside has solved the crystal structure for an enzyme that plays a key role in DNA methylation, the process by which methyl groups are added to the DNA molecule.

DNA methylation alters . This fundamental cellular mechanism critically influences plant, animal, and human development. It is known to regulate genome stability and cell differentiation. In humans, errors in methylation have been associated with various diseases, including cancer.

In mammals, DNA methylation is established de novo (afresh) by closely related enzymes, DNMT3A and DNMT3B, during germ cell development and . One difficulty in understanding how de novo DNA methylation works is that the structures of these enzymes are not known.

The UC Riverside-led team has now solved the crystal structure for substrate-bound DNMT3A. This breakthrough reveals how the enzyme recognizes and methylates its substrates—important information for understanding de novo DNA methlylation. A substrate is a material or substance on which an enzyme acts.

"The structure reveals that DNMT3A molecules attack two substrate sites adjacent to each other on the same DNA molecule," said Jikui Song, an associate professor of biochemistry who led the research project. "This now offers us a much clearer view on how de novo DNA methylation takes place. Our work presents the first structural view of de novo DNA methylation and presents a model for how some DNMT3A mutations contribute to cancers, such as acute myeloid leukemia. This study should provide important insights into the function of DNMT3B as well."

Song explained the structural knowledge of DNMT3A will allow scientists to control DNA methylation content, gene expression, and cell differentiation—all of which are linked to diseases and finding cures for them.

"It especially has important implications in cancer therapy in the long term," he said.

Study results appear today in Nature.

The DNMT3A structure that Song's team cracked explains why mammalian DNA methylation predominantly occurs at "CpG dinucleotides"—DNA locations where cytosine nucleotides are next to guanidine nucleotides.

"Before our study, why mammalian DNA methylation mostly occurs at the CpG sites was not understood, and our understanding of de novo DNA methylation was purely based on computational modeling, which cannot reliably explain how DNMT3A works," Song said. "Just how DNMT3A succeeded in binding to its substrate was not understood either. Our structure for DNMT3A-DNA complex addresses all these concerns, offering a far better understanding of how specific DNA methylation patterns are generated."

The study of DNMT3A structure with substrates has long been hindered by the difficulty in producing a stable enzyme-substrate complex.

"To overcome this challenge, we successfully developed a method to trap the reaction intermediate of DNMT3A-substrate complex, and solved the structure by X-ray crystallography," Song said.

He was joined in the study by Zhi-Min Zhang (first author of the research paper), Pengcheng Wang, Yang Yu, Linfeng Gao, Shuo Liu, Debin Ji, and Yinsheng Wang at UCR; and Rui Lu, Dong-Liang Chen, Scott B Rothbart, and co-leader Gang Greg Wang at the University of North Carolina at Chapel Hill. The Song group solved the . The Wang group performed genomic DNA methylation analysis.

Explore further: Important mechanism of epigenetic gene regulation identified

More information: Zhi-Min Zhang et al, Structural basis for DNMT3A-mediated de novo DNA methylation, Nature (2018). DOI: 10.1038/nature25477

Related Stories

Important mechanism of epigenetic gene regulation identified

October 30, 2017
How can defective gene activity leading to cancerbe avoided? Researchers at the University of Zurich have now identified a mechanism by which cells pass on the regulation of genetic information through epigenetic modifications. ...

Study reveals new insight into 'immortal' plant cells

December 18, 2017
A new study has revealed an undiscovered reprogramming mechanism that allows plants to maintain fitness down the generations.

New computational method reveals chemoresistance drug targets

January 30, 2018
Osaka – In cancer, one of the most important features is the methylation of deoxycytosine to form 5-methylcytosine (5mC). DNA methylation is a process by which methyl groups (structural units of organic compounds consisting ...

Two proteins safeguard skin stem cells

July 28, 2016
Our skin renews, heals wounds, and regenerates the hair that covers it thanks to a small group of stem cells. These cells continually produce new ones, which appear on the skin surface after a few days. A study led by ICREA ...

Optogenetics used to kick start gene that plays role in neural defects

February 14, 2017
Purdue University and Indiana University School of Medicine scientists were able to force an epigenetic reaction that turns on and off a gene known to determine the fate of the neural stem cells, a finding that could lead ...

Permanent changes in brain genes may not be so permanent after all

January 27, 2014
In normal development, all cells turn off genes they don't need, often by attaching a chemical methyl group to the DNA, a process called methylation. Historically, scientists believed methyl groups could only stick to a particular ...

Recommended for you

Pushing closer to a new cancer-fighting strategy

December 11, 2018
A molecular pathway that's frequently mutated in many different forms of cancer becomes active when cells push parts of their membranes outward into bulging protrusions, Johns Hopkins researchers report in a new study. The ...

Receiving genetic information can change risk

December 11, 2018
Millions of people in the United States alone have submitted their DNA for analysis and received information that not only predicts their risk for disease but, it turns out, in some cases might also have influenced that risk, ...

HER2 mutations can cause treatment resistance in metastatic ER-positive breast cancer

December 11, 2018
Metastatic breast cancers treated with hormone therapy can become treatment-resistant when they acquire mutations in the human epidermal growth factor receptor 2 (HER2) that were not present in the original tumor, reports ...

Scientists have identified and modelled a distinct biology for paediatric AML

December 11, 2018
Scientists have identified and modelled a distinct biology for paediatric acute myeloid leukaemia, one of the major causes of death in children.

Breast cancer drug could create chink in the armour of pancreatic cancer

December 11, 2018
The well-known drug tamoxifen could exploit a weakness in the physical 'scaffolds' around tumours, according to research led by Imperial.

How glial cells develop in the brain from neural precursor cells

December 11, 2018
Two types of cells are active in the brain: nerve cells and glial cells. Glial cells have long been regarded primarily as supportive cells, but researchers increasingly recognize that they play an active role in the communication ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.